SCHEMBL4808094

SCHEMBL4808094

O=Cc1ccc(F)c(F)c1.[NaH]

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ NFE2L2 Q16236 2/20 0.48
▸ PTGS2 P35354 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ HSD17B10 Q99714 2/20 0.44
▸ KIF11 P52732 1/20 0.41
▸ PLA2G7 Q13093 2/20 0.41
▸ TSHR P16473 1/20 0.40
▸ CES2 O00748 1/20 0.39
▸ CES1 P23141 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ CYP2A6 P11509 2/20 0.39
▸ ALDH5A1 P51649 1/20 0.39
▸ ABAT P80404 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL48607 0.97 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2NFE2L2PTGS2KDM4E
SCHEMBL29389102 0.97 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2NFE2L2PTGS2KDM4E
Hydrazine SCHEMBL27687525 0.93 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2NFE2L2PTGS2KDM4E
Methylene Chloride SCHEMBL27781503 0.89 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2NFE2L2PTGS2KDM4E
Ethylene Glycol SCHEMBL28725409 0.87 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2NFE2L2PTGS2KDM4E
SCHEMBL18002551 0.83 NFE2L2 (0.67) ALDH1A1SMN1; SMN2NFE2L2PTGS2RAB9A
Benzidine SCHEMBL6692243 0.82 KIF11 (0.45) ALDH1A1SMN1; SMN2NFE2L2PTGS2KDM4E
Acrylic Acid SCHEMBL28129825 0.82 PLA2G7 (0.42) ALDH1A1SMN1; SMN2NFE2L2PTGS2KDM4E
SCHEMBL3430702 0.82 NFE2L2 (0.52) ALDH1A1SMN1; SMN2NFE2L2KDM4EPLA2G7
3-Hydroxybenzaldehyde SCHEMBL7545336 0.80 CCNB2 (0.49) ALDH1A1NFE2L2PTGS2KDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7405221-B2 Substituted pyrimidines MERCK & CO., INC. (US) 2008-07-29 — — US disclosed
US-20050245554-A1 Substituted pyrimidines MERCK SHARP & DOHME CORP. 2005-11-03 — — US disclosed
EP-1546115-A2 SUBSTITUTED PYRIMIDINES Merck & Co., Inc. (US) 2005-06-29 — — EP disclosed
WO-2004029204-A2 SUBSTITUTED PYRIMIDINES MERCK & CO., INC. (US) 2004-04-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050245554-A1 Substituted pyrimidines CNR1, CNR2, GPR119 ALDH1A1 3049/4885SMN1; SMN2 710/4885NFE2L2 1642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback